As GLP-1 drugs disrupt the weight loss market, food and beverage players are racing to unlock the appetite-regulating power of functional ingredients While the acronym doesn’t quite yet trip off the ...

China is advancing its "health silk road" in Africa by initiating major offshore projects to manufacture essential medicines, such as insulin and antiretrovirals. Nigeria is set to produce ...

LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are ...

Mohammad Pourhosseinzadeh, M.D./Ph.D. student with Professor Mark Huising, watches undergraduate student Joel Sanchez working at a dissecting microscope. New work led by Pourhosseinzadeh and Huising ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baricitinib preserved C-peptide levels and lowered ...

The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

Federal Government has said it will begin production of insulin in Nigeria as part of efforts to reduce dependence on imported drugs and improve access to affordable diabetes treatment. Minister of ...

When someone is diagnosed with diabetes, it’s usually pretty simple which one they have — Type 1 or Type 2. The rate of diabetes has grown worldwide, having surpassed 800 million people a year ago. By ...

Strictly speaking, based on what we've been told, the answer to the question in the headline is "yes." While official information regarding AMD's next-generation RDNA 5 (or 'UDNA') graphics ...